Peregrine begins investigator-sponsored trial with bavituximab
Linkedin

Peregrine begins investigator-sponsored trial with bavituximab

London : United Kingdom | Jul 17, 2012 at 4:14 AM PDT
Source: Pharmaceutical Industry News
XX XX
Views: Pending
 
The Phase I dose-escalation trial will enrol up to 18 patients with bavituximab in combination with the chemotherapeutic agent capecitabine and radiation therapy. The study principal investigator, the University of Texas Southwestern Medical Center radiation oncology assistant professor... FULL ARTICLE AT Pharmaceutical Industry News
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices

Most Commented Reports



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.